Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation (Request for quotation) from Defense Health Agency. Responses are due Dec 7, 2026 (17 days left).
- 17Days left to respond
- 20 daysThis buyer usually gives
- 12%Notices this buyer changes
- -Typical award from this office
What BidCamel found about this buyer
- This office usually gives bidders 20 days to respond; this notice gives 25 days.
- It changed 12% of its 17 notices after posting, so check for amendments before you submit.
- It has 1 open bids right now. See them all.
- We have no past awards from this office yet.
Key details
- Solicitation number
- HT9402-27-Q-9101
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Size standard for this code
- 1,300 employees
- Set-aside
- Open to all (no set-aside)
- Buying
- Product
- Place
- San Antonio, TX · Texas bids
- Posted
- Nov 12, 2026
- Last changed
- Nov 12, 2026
- Contact
- Contact details are on the SAM.gov notice. Open on SAM.gov
Description
The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following February 2027 drug classes/subclasses will be reviewed: a. Ophthalmic - Dry Eye Cequa Eysuvis Miebo Tryptyr Tyrvaya Verkazia Vevye Xiidra b. Testosterone Replacement Therapy - Orals Jatenzo Kyzatrex Tlando The RFQ, including UF BPA and UF ADP appendices, are attached herein. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-27-Q-9101. Pre-quotation teleconference is on November 17, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference.
Similar open bids
1 day leftNov 20, 2026
Department of Veterans Affairs Pharmaceutical Industry Day
Nac Federal Supply Schedule (36F797)
Special Notice
3 days leftNov 23, 2026
BPA for IV Fluids on an "As Needed Basis"
Navajo Area Indian Health Svc
OtherSources Sought
3 days leftNov 23, 2026
Ramipril Capsules RFP
Nac Pharmaceuticals (36E797)
Presolicitation
5 days leftNov 25, 2026
Charleston CMOP CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15ML
National Cmop Office (36C770)
Small businessPresolicitation
6 days leftNov 25, 2026
766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312)
National Cmop Office (36C770)
Small businessSolicitation
From SAM.gov and USAspending.gov public data. BidCamel adds the buyer and award facts.